Herein, we demonstrated that antagonism of CXCR3 in HPVOPC significantly slowed tumor growth in an immunodeficient model in which the pro-tumor autocrine effect of the CXCR3 axis dominates. This evidence concerns the gene CXCR3 and neoplasm.